ARO- Toenail fungus Study - Adolescent
STUDY BASICS
Do you have a child 12-17 years old? Does your child have toenail fungus? Your child may be eligible to join a clinical research study exploring a potential treatment option for toenail fungus. Compensation provided.
STUDY PURPOSE
The purpose of this study is to test an investigational medication for people with toe nail fungus. This study is to look at whether the study drug works for people with mild to moderate toe nail fungus and how safe the study drug is.
COULD THIS STUDY BE RIGHT FOR YOUR CHILD?
- Have a child 12 to 17 years old
- Your child has at least one big toe that has toenail fungus
WHAT PARTICIPANTS CAN EXPECT
This study has 3 main periods:
1. Screening period (up to 8 weeks)
2. Study treatment period (up to 48 weeks)
3. Follow-up period (up to 4 weeks)
IRB: SSU00193015B
- Moberg Pharma - MOB015B-33-21-001 / SZA55231, A Multi-center, Doubleblind, Randomized, Vehicle-controlled Study of Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) (Pro00061088)MEET THE RESEARCHER

Laura Ferris
Laura Korb Ferris, MD, PhD, is Professor of Dermatology at the University of Pittsburgh School of Medicine, and is also the Director of Clinical Trials for the Department of Dermatology. Dr. Ferris earned her doctorate in immunology from Johns Hopkins University and her medical degree from the University of Maryland.